Journal of hepatologyJClubRifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid.
Journal of hepatology · · Journal Article
Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid.
Xiong, Zhao + more
Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's. The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.
Read the brief in JClub →